Skip to main content

Randomized Phase II Study of Autologous Stem Cell Transplantation With Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma

Date: -
Investigator Address

Baltimore, MD
United States

Grant Program
Therapy Acceleration Program